Answers are grounded in this paper and cite their sources.
BACKGROUND: After a year of quiescence, SARS-CoV-2 activity increased rapidly in Hong Kong since June 2026. We sought to characterize the genomic profile of SARS-CoV-2 driving this COVID-19 surge in Hong Kong and to examine the global dissemination of the identified circulating lineages. METHODS: We performed SARS-CoV-2 whole-genome sequencing on archived respiratory specimens collected at Queen Mary Hospital, Hong Kong, between January 2025 and July 2026. Viral lineages were assigned via Nextclade. Global SARS-CoV-2 metadata downloaded from GISAID as of July 2026 were analyzed to track global evolutionary trends. RESULTS: Among 615 successfully sequenced strains, the XDV descendant NB.1.8.1 was the predominant lineage. Between April and July 2026, NB.1.8.1 descendants accounted for 95.6% (108/113) of sequenced strains, dominated by PQ.16.1.1 (81.5%). Spike substitutions 420N and 478 T emerged rapidly. While 478 T increased gradually throughout 2025, 420N emerged in April 2026 and reached 98.0% by June-July 2026. Strains harboring 420N-478 T dual substitution arose independently across distinct NB.1.8.1 lineages, accounting for 94.4% (102/108) of NB.1.8.1 descendants in Hong Kong during this period. Globally, the prevalence of NB.1.8.1 strains with 420N-478 T dual substitution increased from <1% before April 2026 to 50.7% by mid-July 2026, with the highest prevalence observed in Southeast Asia and Australia. CONCLUSIONS: The 2026 COVID-19 surge in Hong Kong was driven by NB.1.8.1 descendants harboring spike 420N and 478 T substitutions. The rapid worldwide expansion of these dual-substitution lineages highlights their competitive growth advantage and underscores the need for continued global genomic surveillance.
No takes yet. Share an insight, caveat, or question.
Tsoi et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: